A podcast about neuroscience, philosophy and everything inbetween! Hosted by Clara and Carolina, two young neuroscientists. For business enquiries please email neuroverse.cc@gmail.com Support us! https://ko-fi.com/neuroverse Website: https://neuroversepod.com Merchandise: https://neuroversepod.teemill.com Twitter: https://twitter.com/neuroverse_pod?s=21&t=-w2l8EvODnu0XwZmJR_X9g Instagram: https://www.instagram.com/neuroverse_pod/?igshid=ZjE2NGZiNDQ%3D&__coig_restricted=1 Help us improve our ...
…
continue reading
Dissection and discussion of science and science issues made digestible for public consumption. Find us on Facebook and Twitter! The intro and outro theme is Soft Illusion and was generously provided by Andras. https://andras.bandcamp.com/track/soft-illusion
…
continue reading
In this show, Jen Novakovich, Canadian cosmetic chemist from The Eco Well, interviews international cosmetic scientists and industry leaders to bring you a fresh new conversation a week about all things beauty!
…
continue reading
Biodegradable Bill is a Podcast of End Times Revelation This is a profound podcast dedicated to exploring the timeless truths of Christian faith, focusing on the significance of the end times, the essence of Protestant doctrine, and the transformative power of the Gospel message. Join us as we delve deep into biblical prophecies, unraveling the mysteries of the last days, and discerning the signs of the times according to scripture. Our mission is to illuminate the path of faith, guiding bel ...
…
continue reading
Welcome to the official Menswear Style Podcast, hosted by Peter Brooker. In this men's fashion, men's style, men’s grooming and men’s lifestyle focused podcast we speak to some of the most influential designers, innovative brand founders and truly inspiring entrepreneurs from within the fashion and apparel industry. Our aim is to bring you a detailed insight into founder start-up stories with a focus on sustainability, marketing, design, manufacturing, eCommerce, and operations.
…
continue reading
We are here to update you on the latest research about BDM and recycling options PE mulch as well as help you to answer any questions you might have. In each episode, we’ll dive into the latest research, trends, news, and insights on why mulch matters and how we can improve plastic mulch end-of-life options. We'll also branch out and discuss other plastics as well as talk to researchers, experts, and practitioners in the field who will share their insights and experiences on how to use mulch ...
…
continue reading
Stories of learning in and out of school, and interviews with teachers, students, and school leaders. Artwork by the inimitable Enrique "Chikle" Lugo Brought to you by HTH Unboxed: A Journal of Adult Learning in Schools Visit us online at hthunboxed.org
…
continue reading
Each week, Valentin Fuster, MD, PhD, MACC, records free podcasts highlighting journal findings. To keep clinicians updated on the most important science emerging in clinical and translational cardiology, Dr. Fuster provides an overview of the weekly edition from the Journal of the American College of Cardiology (JACC), as well as a short summary of each manuscript. Encompassing JACC and nine cardiovascular specialty journals, the JACC family of journals rank among the top cardiovascular peer ...
…
continue reading
Dedicated to Environmental News that you do not hear in the Media ! Conservation is Key !
…
continue reading
Your source for all things foodservice and hospitality related! Join us for industry expert interviews, product reviews and trending news all centered around helping owners, operators, and foodservice professionals stay on top of industry trends, best practices and cost-saving solutions that help their businesses run more efficiently and drive revenue to their bottom line.
…
continue reading
We, the Ratchet Aunties are here to drop a wealth of game on our beautiful fam. We may get a little ratchet sometimes, but we always gon keep it classy, cute and above all…we gon keep it real.
…
continue reading
Since childhood, we’ve all been taught the importance of character, but lately, the world seems to have forgotten just how valuable it truly is. We want to help change that. Return on Character Podcast tells character-shaping stories with famous and should-be famous leaders. Our hope is these stories will show the next generation, our country, and the world, that not only does character matter, but it’s the best way to live and INVEST. Podcast Disclosure
…
continue reading
An environmental podcast with tips on how to live plastic free! Host Andrea Fox tackles big ethical issues with her knowledgeable guests, all in the hope of overcoming the climate change overwhelm and battling the single-use plastic guilt.
…
continue reading
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up to date on the latest breakthroughs in medical technology with the top five news stories to get your day started. Subscribe and join us every weekday for your daily medtech news roundup.
…
continue reading
1
Personalising exercise plans for cardiovascular disease, better dental implants and biodegradable glitter
51:37
51:37
Spela senare
Spela senare
Listor
Gilla
Gillad
51:37
Dr Shane is in the studio with Dr Linden, sharing some science news about the hunt for new prime numbers via citizen science, and recent research combining images from the Hubble and Webb telescopes to show what nearby star Vega really looks like. This week's guests include Dr Kim Way from the School of Exercise and Nutrition Sciences at Deakin Uni…
…
continue reading
1
Mulch matters: exploring the impact of plastic (PE) and biodegradable (BDM) mulches in agriculture
32:21
32:21
Spela senare
Spela senare
Listor
Gilla
Gillad
32:21
In this episode of Mulch Matters, we are joined by Dr. Lisa DeVetter, Associate Professor in the Department of Horticulture at Washington State University and our project director. We dive into the fascinating world of mulch and its significant impact on agriculture and the environment. Dr. DeVetter shares insights into the history, benefits, and g…
…
continue reading
1
Randomized Comparison of Novel Low-Dose Sirolimus-Eluting Biodegradable Polymer Stent vs. Second-Generation DES: TARGET-IV NA Trial
13:53
13:53
Spela senare
Spela senare
Listor
Gilla
Gillad
13:53
Author Robert W. Yeh, MD, FACC, and JACC Associate Editor Celina M. Yong, MD, FACC, discuss the results of the TARGET-IV NA trial. In the trial, 1720 patients with stable or acute coronary syndromes were randomized to undergo PCI with a BP-SES or any commonly used 2nd generation DES. At 12 months, BP-SES was non-inferior to control DES for the prim…
…
continue reading
1
Biodegradation and Persistence with Chris Hughes
43:58
43:58
Spela senare
Spela senare
Listor
Gilla
Gillad
43:58
With the press around "forever chemicals" and the moving regulations related to biodegradation, the topics of biodegradation and persistence are increasingly important to understand. This episode is a deep dive into the topic, featuring Chris Hughes from Embark Chemical Consulting. Disclaimer, this one is a little more into the weeds, but a good 10…
…
continue reading
1
Complete vs. Culprit-Only Revascularization in Older Patients with Myocardial Infarction with or without ST-segment elevation
10:28
10:28
Spela senare
Spela senare
Listor
Gilla
Gillad
10:28
In this episode, Dr. Valentin Fuster discusses a pivotal study on revascularization strategies in older patients with myocardial infarction, comparing complete versus culprit-only approaches. The findings suggest that physiology-guided complete revascularization significantly reduces adverse outcomes in both STEMI and non-STEMI patients, emphasizin…
…
continue reading
1
Recaticimab Monotherapy for Non-Familial Hypercholesterolemia and Mixed Hyperlipemia: The Phase 3 REMAIN-1 Randomized Trial
18:42
18:42
Spela senare
Spela senare
Listor
Gilla
Gillad
18:42
In this episode, Dr. Valentin Fuster reviews two pivotal phase three trials from China assessing the efficacy of the new monoclonal antibody, Katisha, for treating non-familial hypercholesterolemia. With significant reductions in LDL cholesterol and a long-acting, flexible dosing regimen, these studies promise a novel therapeutic option for patient…
…
continue reading
1
Comprehensive Proteomic Profiling of Human Myocardium Reveals Signaling Pathways Dysregulated in Hypertrophic Cardiomyopathy
12:16
12:16
Spela senare
Spela senare
Listor
Gilla
Gillad
12:16
In this episode, Dr. Valentin Fuster discusses groundbreaking research on hypertrophic cardiomyopathy (HCM), revealing dysregulated signaling pathways through comprehensive proteomic profiling of human myocardial tissue. The study identifies novel therapeutic targets, including the Ras MAPK pathway and the ubiquitin-proteasome system, while emphasi…
…
continue reading
1
Artificial Intelligence in Cardiovascular Clinical Trials
28:08
28:08
Spela senare
Spela senare
Listor
Gilla
Gillad
28:08
In this episode, Dr. Valentin Fuster delves into the transformative potential of artificial intelligence (AI) in cardiovascular clinical trials, guided by a comprehensive review from leading experts. Highlighting both innovative applications and regulatory challenges, the discussion emphasizes AI's role in trial design, patient recruitment, and dat…
…
continue reading
1
JACC - November 12, 2024 Issue Summary
24:38
24:38
Spela senare
Spela senare
Listor
Gilla
Gillad
24:38
In this episode, Dr. Valentin Fuster highlights the groundbreaking studies featured in the November 12, 2024 issue of the JACC, focusing on the emerging role of proteomics in understanding heart failure and hypertrophic cardiomyopathy. He discusses key findings on SGLT2 inhibitors, the efficacy of complete revascularization in myocardial infarction…
…
continue reading
1
Reaffirmation of Mechanistic Proteomic Signatures Accompanying SGLT2 Inhibition in Heart Failure: a EMPEROR Validation Cohort
11:30
11:30
Spela senare
Spela senare
Listor
Gilla
Gillad
11:30
In this episode, Dr. Valentin Fuster discusses groundbreaking research on SGLT2 inhibitors and their impact on heart failure, highlighting the validation of mechanistic proteomic signatures from a major clinical trial. The study reveals how empagliflozin influences over 2,000 proteins, promoting autophagy, enhancing mitochondrial health, and normal…
…
continue reading
1
Recaticimab as add-on therapy to statins for non-familial hypercholesterolaemia: the phase 3 REMAIN-2 trial
18:42
18:42
Spela senare
Spela senare
Listor
Gilla
Gillad
18:42
In this episode, Dr. Valentin Fuster reviews two pivotal phase three trials from China assessing the efficacy of the new monoclonal antibody, Katisha, for treating non-familial hypercholesterolemia. With significant reductions in LDL cholesterol and a long-acting, flexible dosing regimen, these studies promise a novel therapeutic option for patient…
…
continue reading
1
86. Laugh and the World Laughs With You: The Science of Laughter in Humans and Other Animals (with Professor Sophie Scott)
40:16
40:16
Spela senare
Spela senare
Listor
Gilla
Gillad
40:16
In today's episode, we are joined by Sophie Scott, a professor in cognitive neuroscience and head of the speech communications group at University College London. Her research focuses on the neural basis of vocal communication- how our brains process information in speech and control the production of our voice- as well as the expression of emotion…
…
continue reading
1
Quality of Life After Transcatheter Tricuspid Valve Replacement: 1-Year Results From TRISCEND II Pivotal Trial
10:51
10:51
Spela senare
Spela senare
Listor
Gilla
Gillad
10:51
In this episode of JACC, Author Suzanne Arnold, MD and JACC Associate Editor Dennis T. Ko, MD, discusses groundbreaking findings from the Tricatin-2 trial, the first clinical study on transcatheter tricuspid valve replacement. The results reveal significant improvements in quality of life for patients, particularly those with severe tricuspid regur…
…
continue reading
1
S6E5 - Ron Berger: Empower Children by Giving Them Learning Targets
51:08
51:08
Spela senare
Spela senare
Listor
Gilla
Gillad
51:08
Episode Notes Leaders of Their Own Learning by Ron Berger, Leah Woodfin, and Leah RugenOther podcast episodes featuring Ron Berger: Ron Berger on Presentations of Learning Ron Berger on Student-Led Conferences Ron Berger on Whole-Class Close Reading Ron Berger on Beautiful Lessons and “No Lesson at All”…
…
continue reading
1
Drug-Coated Balloon Angioplasty Of the Side Branch During Provisional Stenting: The Multicenter Randomized DCB-BIF Trial
23:05
23:05
Spela senare
Spela senare
Listor
Gilla
Gillad
23:05
Author Shao-Liang Chen, MD, FACC, and JACC Associate Editor Celina M. Yong, MD, FACC, discuss patients with simple and true coronary bifurcation lesions undergoing provisional stenting. Main vessel stenting with a DCB for the compromised side branch resulted in a lower 1-year rate of the composite outcome compared with an NCB intervention for the s…
…
continue reading
1
Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis: TAVR UNLOAD
15:49
15:49
Spela senare
Spela senare
Listor
Gilla
Gillad
15:49
Author Nicolas M. Van Mieghem, MD, PhD, FACC, and JACC: Executive Associate Editor Aakriti Gupta, MD, FACC, discuss the TAVR UNLOAD trial, which focused on patients with moderate aortic stenosis (AS) and reduced ejection fraction (HFrEF). The trial found no significant difference in the primary endpoint (composite of mortality, stroke, and hospital…
…
continue reading
1
Standard of Care Medication Withdrawal in Patients With Obstructive Hypertrophic Cardiomyopathy Receiving Aficamten in FOREST-HCM
11:40
11:40
Spela senare
Spela senare
Listor
Gilla
Gillad
11:40
In this episode, Dr. Valentin Fuster highlights the Forest HCM study, which focuses on the withdrawal of standard care medications in patients with obstructive hypertrophic cardiomyopathy receiving afficantin. The study shows promising results: nearly half of the patients who attempted to reduce or stop their medications did so successfully, with s…
…
continue reading
1
Family Screening in Hypertrophic Cardiomyopathy - Identification of Relatives with Low Yield from Systematic Follow-up
13:52
13:52
Spela senare
Spela senare
Listor
Gilla
Gillad
13:52
In this episode, Dr. Valentin Fuster dives into a pivotal study on hypertrophic cardiomyopathy, focusing on the challenges of identifying at-risk relatives when genetic variants are not found in 60% of families. With insights into the disease's autosomal dominant inheritance and incomplete penetrance, this discussion highlights the complexities of …
…
continue reading
1
Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results from SEQUOIA-HCM
9:09
9:09
Spela senare
Spela senare
Listor
Gilla
Gillad
9:09
In this episode, Dr. Valentin Fuster introduces a dedicated focus on hypertrophic cardiomyopathy, featuring a pivotal study by Dr. Martin Maron and Dr. lacopo Olivotto on the impact of aficamptin. This pre-specified sub-analysis from the SEQUOIA HCM trial aims to comprehensively evaluate the drug's effects on various aspects of disease burden, enha…
…
continue reading
1
Effect of Aficamten on Cardiac Structure and Function in Obstructive Hypertrophic Cardiomyopathy: SEQUOIA-HCM CMR Substudy
12:20
12:20
Spela senare
Spela senare
Listor
Gilla
Gillad
12:20
In this episode, Dr. Valentin Fuster explores groundbreaking research on hypertrophic cardiomyopathy, focusing on the effects of the drug aficamten on cardiac structure and function. Highlighting significant findings from the Sequoia HCM trial, the discussion underscores the potential of aficamten to induce favorable cardiac remodeling and improve …
…
continue reading
1
Effect of Aficamten on Health Status Outcomes in Obstructive Hypertrophic Cardiomyopathy: Results from SEQUOIA-HCM
10:36
10:36
Spela senare
Spela senare
Listor
Gilla
Gillad
10:36
In this episode, Dr. Valentin Fuster delves into the latest research on hypertrophic cardiomyopathy, highlighting the significant health status improvements achieved with the new cardiac myosin inhibitor, Aficamten, compared to placebo. The findings from the Sequoia HCM study reveal that Aficamten markedly enhances patients' quality of life and all…
…
continue reading
1
Impact of Aficamten on Echocardiographic Cardiac Structure and Function in Symptomatic Obstructive Hypertrophic Cardiomyopathy
10:06
10:06
Spela senare
Spela senare
Listor
Gilla
Gillad
10:06
In this episode, Dr. Valentin Fuster delves into a groundbreaking study on the effects of the cardiac myosin inhibitor, Aficamten, on patients with obstructive hypertrophic cardiomyopathy. The findings reveal significant improvements in echocardiographic measures of cardiac function, despite a mild and reversible decrease in left ventricular ejecti…
…
continue reading
1
JACC - November 5, 2024 Issue Summary
23:49
23:49
Spela senare
Spela senare
Listor
Gilla
Gillad
23:49
In the November 5, 2024 issue of JACC, Dr. Valentin Fuster summarizes the November 5, 2024 issue of the JACC, which focuses exclusively on hypertrophic cardiomyopathy (HCM). Highlighting six original research papers, the discussion emphasizes the groundbreaking impact of the cardiac myosin inhibitor Aficamten on health outcomes, symptom burden, and…
…
continue reading